[1] SUNG H,FERLAY J,SIEGEL R L,et al.Global cancer statistics 2020:Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249. [2] CAO W,CHEN H D,YU Y W,et al.Changing profiles of cancer burden worldwide and in China:A secondary analysis of the global cancer statistics 2020[J].Chin Med J(Engl),2021,134(7):783-791. [3] HUVILA J,PORS J,THOMPSON E F,et al.Endometrial carcinoma:Molecular subtypes,precursors and the role of pathology in early diagnosis[J].J Pathol,2021,253(4):355-365. [4] SOSLOW R A,TORNOS C,PARK K J,et al.Endometrial carcinoma diagnosis:Use of FIGO grading and genomic subcategories in clinical practice:Recommendations of the international society of gynecological pathologists[J].Int J Gynecol Pathol,2019,38 Suppl 1(Iss 1 Suppl 1):S64-S74. [5] HERMAN A B,TSITSIPATIS D,GOROSPE M.Integrated lncRNA function upon genomic and epigenomic regulation[J].Mol Cell,2022,82(12):2252-2266. [6] RINN J L,CHANG H Y.Long noncoding RNAs:Molecular modalities to organismal functions[J].Annu Rev Biochem,2020(89):283-308. [7] KOPP F,MENDELL J T.Functional classification and experimental dissection of long noncoding RNAs[J].Cell,2018,172(3):393-407. [8] ADNANE S,MARINO A,LEUCCI E.LncRNAs in human cancers:Signal from noise[J].Trends Cell Biol,2022,32(7):565-573. [9] BATISTA P J,CHANG H Y.Long noncoding RNAs:Cellular address codes in development and disease[J].Cell,2013,152(6):1298-1307. [10] BHAN A,SOLEIMANI M,MANDAL S S.Long noncoding RNA and cancer:A new paradigm[J].Cancer Res,2017,77(15):3965-3981. [11] FANG Y,FULLWOOD M J.Roles,functions,and mechanisms of long non-coding RNAs in cancer[J].Genomics Proteomics Bioinformatics,2016,14(1):42-54. [12] LIU W,ZHANG Z,LUO X,et al.m6A-mediated LINC02038 inhibits colorectal cancer progression via regulation of the FAM172A/PI3K/AKT pathway via competitive binding with miR-552-5p[J].Int J Oncol,2023,63(1):81. [13] MAKKER V,MACKAY H,RAY-COQUARD I,et al.Endometrial cancer[J].Nat Rev Dis Primers,2021,7(1):88. [14] CHEN W,ZHENG R,BAADE P D,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132. [15] BROOKS R A,FLEMING G F,LASTRA R R,et al.Current recommendations and recent progress in endometrial cancer[J].CA Cancer J Clin,2019,69(4):258-279. [16] YAO Z T,YANG Y M,SUN M M,et al.New insights into the interplay between long non-coding RNAs and RNA-binding proteins in cancer[J].Cancer Commun(Lond),2022,42(2):117-140. [17] CHEN L L.Linking long noncoding RNA localization and function[J].Trends Biochem Sci,2016,41(9):761-772. [18] TAN Y T,LIN J F,LI T,et al.LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer[J].Cancer Commun(Lond),2021,41(2):109-120. [19] DONG P,XIONG Y,KONNO Y,et al.Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2/miR-181a pathway[J].J Exp Clin Cancer Res,2021,40(1):216. [20] LIU Y,CAI X,CAI Y,et al.IncRNA OIP5-AS1 suppresses cell proliferation and invasion of endometrial cancer by regulating PTEN/AKT via sponging miR-200c-3p[J].J Immunol Res,2021(2021):4861749. [21] ZHAO H,YIN X,WANG L,et al.Identifying tumour microenvironment-related signature that correlates with prognosis and immunotherapy response in breast cancer[J].Sci Data,2023,10(1):119. [22] DIÉGUEZ-MARTÍNEZ N,ESPINOSA-GIL S,YOLDI G,et al.The ERK5/NF-kB signaling pathway targets endometrial cancer proliferation and survival[J].Cell Mol Life Sci,2022,79(10):524. [23] RUAN P,WANG S,YANG C,et al.m6A mRNA methylation regulates the ERK/NF-κB/AKT signaling pathway through the PAPPA/IGFBP4 axis to promote proliferation and tumor formation in endometrial cancer[J].Cell Biol Toxicol,2023,39(4):1611-1626. |